Oculis Holding AG (OCS) Enterprise Value (2021 - 2026)
Oculis Holding AG (OCS) reported Enterprise Value of $435.73 million for Q2 2026, down 26.2% from $590.67 million a year earlier and down 60.6% from the prior quarter.
Powered by 
Analysis
Oculis Holding AG (OCS) Enterprise Value (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Oculis Holding AG's Enterprise Value came in at -$295.82 million; for FY2025, it was $776.78 million, up 35.1% from FY2024.
- Enterprise Value has increased for four consecutive years, with a four-year compound annual growth rate of 68.9% (FY2021 to FY2025).
- By year, Enterprise Value came in at $574.76 million in FY2024 (+62.5%), $353.63 million in FY2023 (+168.9%), $131.53 million in FY2022 (+37.8%) and $95.44 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Enterprise Value since Q3 2024.
- Year over year, Enterprise Value gained in seven of the last eight quarters, with growth averaging 70.8%.
- The high point for year-over-year Enterprise Value in five years was Q4 2023 (growth of 168.4%); the low point was Q2 2026 (a decline of 26.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.11 billion (Q1 2026), $776.78 million (Q4 2025) and $528.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Oculis Holding AG | 473.32 Mn | 473.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 435.73 Mn |
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | 776.78 Mn |
| Sep 30, 2025 | 528.86 Mn |
| Jun 30, 2025 | 590.67 Mn |
| Mar 31, 2025 | 566.59 Mn |
| Dec 31, 2024 | 574.29 Mn |
| Sep 30, 2024 | 244.83 Mn |
| Jun 30, 2024 | 226.90 Mn |
| Mar 31, 2024 | 268.71 Mn |
| Dec 31, 2023 | 353.63 Mn |
| Sep 30, 2023 | 217.01 Mn |
| Jun 30, 2023 | 219.48 Mn |
| Mar 31, 2023 | 112.05 Mn |
| Dec 31, 2022 | 131.73 Mn |
| Sep 30, 2022 | 149.46 Mn |
| Jun 30, 2022 | 147.65 Mn |
| Dec 31, 2021 | 95.89 Mn |
API Access
Oculis Holding AG Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=OCS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "OCS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=OCS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();